USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Strategic Analysis of the Opportunities for the Pharmaceutical and Biotechnology Industry in the 'New' EU Countries
Strategic Analysis of the Opportunities for the Pharmaceutical and Biotechnology Industry in the 'New' EU Countries
RELEASE DATE
16-Dec-2004
16-Dec-2004
REGION
Europe
Europe
Research Code: B518-01-00-00-00
SKU: HC01083-EU-MR_05119
$3,950.00
In stock
SKU
HC01083-EU-MR_05119
Description
This strategic analysis service looks into the market entry issues in the 'new' European Union (EU) countries. The service in powerpoint format (approximately 90 slides) focuses not just on the challenges for pharmaceutical and biotechnology companies wishing to enter the 'new' EU countries but also identifies opportunities within the 'new' EU for market growth. The research also looks into the strategies for achieving the maximum growth in the 'new' EU by the pharmaceutical and biotechnology companies.
Table of Contents
Overview
- Overview
Research Scope and Methodology
- Research Scope and Methodology
European Union
- European Union
European Union Healthcare
- European Union Healthcare
'New' EU Markets- The Facts
- 'New' EU Markets- The Facts
Challenges in the 'New' EU Market
- Challenges in the 'New' EU Market
Opportunities in Clinical Trials
- Opportunities in Clinical Trials
Strategic Recommendations
- Strategic Recommendations
Industry Participants
- Industry Participants
Decision Support Databases
- Decision Support Databases
About Frost & Sullivan
- Our Team
- Consulting Capabilities
Popular Topics
This strategic analysis service looks into the market entry issues in the 'new' European Union (EU) countries. The service in powerpoint format (approximately 90 slides) focuses not just on the challenges for pharmaceutical and biotechnology companies wishing to enter the 'new' EU countries but also identifies opportunities within the 'new' EU for market growth. The research also looks into the strategies for achieving the maximum growth in the 'new' EU by the pharmaceutical and biotechnology companies.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | B518-01-00-00-00 |
| Is Prebook | No |